U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506551) titled 'Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome' on March 26.

Brief Summary: Determination of proteins and their levels in the vitreous of eyes with or without pseudoexfoliation syndrome (PEX)

Study Start Date: July 06, 2023

Study Type: INTERVENTIONAL

Condition: Pseudoexfoliation Syndrome

Intervention: OTHER: Liquid chromatography mass spectrometry

Proteomic analysis of vitreous samples of patients with epiretinal membranes or macular holes with or without pseudoexfoliation syndrome using Liquid chromatography mass spectrometry

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Prim. Prof. Dr. Oliv...